Respiratory System Disorders Summary
Respiratory System Disorders
Congenital Disorders
- Bronchial Atresia: Narrowing of the bronchus.
- Hypoplasia of Lung: Smaller than normal lung size.
- Bronchogenic Cysts: Cysts containing a significant amount of mucus.
- Bronchopulmonary Sequestration: A portion of the lung that does not connect or communicate with the bronchial tree.
- Kartagener's Syndrome (Immotile Cilia Syndrome): Defective cilia function.
- Neonatal Respiratory Distress Syndrome (NRDS): Deficiency of surfactant, leading to alveolar collapse (atelectasis).
- Cystic Fibrosis:
- Caused by a CF gene mutation, resulting in the production of abnormally viscous mucus that cannot be effectively cleared from the lungs.
- Leads to recurrent infections.
- Can cause bronchiectasis and haemoptysis (coughing up blood).
- May result in hyperinflation and pneumothorax.
- Can progress to necrosis and scarring.
- May lead to pulmonary hypertension and cor pulmonale.
Circulatory Disorders
- Chronic Venous Congestion:
- Decreased left ventricular (LV) output leads to rupture of alveolar capillaries.
- Can cause haemorrhage, necrosis, and fibrosis.
- Results in brown induration.
- Pulmonary Oedema:
- Caused by congestive heart failure, infections, gas inhalation, or radiation.
- Leads to dyspnoea (shortness of breath) and hypostatic pneumonia.
- Pulmonary Embolism:
- In more than 80% of cases, originates from deep leg veins.
- Causes dyspnoea, tachycardia, and shock.
- Can result in infarction or fatal "saddle embolus."
- Pulmonary Infarction:
- Occurs in elderly or post-operative patients, or patients with heart failure.
- Caused by thromboemboli.
- Results in dyspnoea, scarring, or death.
- Pulmonary Hypertension:
- Primary hypertension is rare.
- Secondary hypertension is due to lung or heart disease.
- Causes dyspnoea and plexiform lesions.
Chronic Obstructive Pulmonary/Airways Disease (COPD/COAD)
- A disease state characterized by persistent airflow limitation that is not fully reversible.
- Symptoms include dyspnoea (shortness of breath), cough, and sputum production.
- Emphysema:
- Enlargement of alveolar spaces and loss of elastic recoil (distal to the terminal bronchiole).
- Familial: Due to inherited defect in α-1-antiproteinase.
- Acquired: Smoking leads to decreased α-1-antiproteinase, which cannot inactivate elastases released by neutrophils, resulting in the destruction of elastic tissue in alveolar walls.
- Bronchiectasis:
- Permanent dilatation of bronchi and bronchioles.
- Results in recurrent cough and copious mucus production.
- Due to chronic infections, TB/sarcoidosis, smoking/scarring, dust inhalations, tumors, cystic fibrosis, or immotile cilia syndrome.
- Chronic Bronchitis & Bronchiolitis:
- Mucous hypersecretion and inflammation of airways, leading to airway narrowing.
- Due to smoking, dust/fume inhalations, or infections/inflammations.
Bronchial Asthma
- Reversible bronchospasm causing wheezing and excess mucus, mediated by Type I hypersensitivity.
- Extrinsic Asthma: Triggered by allergic or environmental factors.
- Intrinsic Asthma: Triggered by exercise, stress, or psychogenic factors.
- Sequelae: Mild disease, status asthmaticus, chronic asthma, COPD.
Infections & Inflammations
- Lobar Pneumonia:
- More common in young adults, often caused by S. pneumoniae.
- Affects whole lung lobe(s).
- Typically has an 8-day course and resolves.
- Bronchopneumonia:
- More common at age extremes, caused by different flora.
- Results in patchy lesions and an irregular course with pus and fibrosis.
- Tuberculosis:
- Caseating granulomatous inflammation.
- Airborne transmission of M. tuberculosis leads to tubercle formation.
- Viral Infections:
- Caused by influenza, rhinovirus, coxsackievirus, echovirus, SARS coronavirus, or CMV.
- Fungal Infections:
- Caused by Aspergillus spp, Cryptococcus spp, Candida albicans, or Pneumocystis jiroveci (formerly carinii).
- Sarcoidosis:
- Idiopathic, granulomatous inflammation, more common in women.
- Associated with immune anomalies and a positive Kveim-Siltzback skin test.
- Adult Respiratory Distress Syndrome (ARDS):
- Diffuse alveolar damage due to septicaemia, major trauma, toxic smoke/fume inhalation, amniotic fluid embolism, DIC, radiation injury, or chemotherapy.
- Has a high mortality rate (70% in the acute phase).
Pneumoconioses
- Organic:
- Byssinosis (cotton protein).
- Bagassosis (sugar cane refuse).
- Farmers’ lung (mouldy hay).
- Suberosis (cork dust).
- Inorganic:
- Anthracosis: Carbon; Commonly found in cigarette smokers; Mostly harmless.
- Silicosis: Silica; Quarry workers, stone masons; Predisposes to TB, COPD, and right heart (RH) problems.
- Silicoanthracosis: Carbon & silica; Coal workers; Results similar to silicosis.
- Berylliosis: Beryllium; Miners, electronics industry; Can lead to granulomas and COPD.
- Silicosiderosis: Silica & iron; Miners, iron ore workers; Predisposes to TB, lung malignancy.
- Asbestosis: Asbestos; Miners, building/automotive industries; Most harmful; Leads to asbestosis, COPD, and mesothelioma of pleura.
Tumours
- Mesothelioma of the Pleura:
- Exposure to asbestos.
- Highly malignant; death usually within 10 months of diagnosis.
- Carcinoma of Bronchus:
- Due to smoking, X-rays, γ-rays, Radon gas, asbestosis, silicosiderosis, or mining of Ni, Cr.
- Can be central (~55%), peripheral (~40%), or diffuse (~5%).
- May cause Pancoast/Horner’s syndromes.
- Diagnosis: Chest X-ray, bronchoscopy & biopsy, needle biopsy, sputum cytology, MRI/CT/bone & brain scans.
- Treatment: Surgery, radiotherapy, chemotherapy, or combined treatments.
- Morphology:
- Squamous cell carcinoma (~50%).
- Small cell anaplastic ca. (“oat cell” ~20%, worst prognosis).
- Large cell anaplastic ca. (~10%).
- Adenocarcinoma (~15%).
- Alveolar cell carcinoma (~5%, best prognosis).
- Staging: TNM (Tumour TX, TIS, T1, T2, T3; Lymph node N0, N1, N2; Metastasis M0, M1); Average 5-year survival <10%.
- Secondary Tumours: Breast, bone, skin, and kidney tumors commonly metastasize to the lung.